Abstract

Pharmacoeconomics has been defined as "the description and analysis of the costs of drug therapy to health care systems and society" Pharmacoeconomic research identifies, measures, and compares the costs (resources consumed),and consequences (clinical, economics, and humanistic) of pharmaceutical product and services. Within this framework, research and methods related to cost-minimization, cost-effectiveness, quality-of-life and other humanistic assessments are included. In-essence, pharmacoeconomic analysis uses tools for examining the impact of alternative drug therapies and other medical interventions. The goal of this study is to explain about the roles of pharmacoeconomics on health servicesm Indonesia. Through descriptive analysis method, the results present pharmaceutical analysis status in Indonesia, the principle of pharmacoeconomics, cost-utility analysis, decision analysis, and pharmacoeconomic guidance for health system services as well. Besides, pharmaceutical products in public health legislation, post marketing surveillance, relationship between pharmacoeconomic evaluation and clinical trials, as well as pharmacoeconomic application in social health insurance are presented. Pharmaceutical products utilization in health services followed by cost utility evaluation and cost effectiveness as well as impact evaluation of quality adjusted life years of patients become important conclusions of the study. Key words: Pharmacoeconomics, drug therapy, health services, quality of life